Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

Saurabhi Samant; Jules Joel Bakhos; Wei Wu; Shijia Zhao; Ghassan S. Kassab; Behram Khan; Anastasios Panagopoulos; Janaki Makadia; Usama M. Oguz; Akshat Banga; Muhammad Fayaz; William Glass; Claudio Chiastra; Francesco Burzotta; John F. LaDisa; Paul Iaizzo; Yoshinobu Murasato; Gabriele Dubini; Francesco Migliavacca; Timothy Mickley; Andrew Bicek; Jason Fontana; Nick E.J. West; Peter Mortier; Pamela J. Boyers; Jeffrey P. Gold; Daniel R. Anderson; James E. Tcheng; John R. Windle; Habib Samady; Farouc A. Jaffer; Nihar R. Desai; Alexandra Lansky; Carlos Mena-Hurtado; Dawn Abbott; Emmanouil S. Brilakis; Jens Flensted Lassen; Yves Louvard; Goran Stankovic; Patrick W. Serruys; Eric Velazquez; Pierre Elias; Deepak L. Bhatt; George Dangas; Yiannis S. Chatzizisis

doi:10.1016/j.jcin.2023.07.022

Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

Saurabhi Samant, Jules Joel Bakhos, Wei Wu, Shijia Zhao, Ghassan S. Kassab, Behram Khan, Anastasios Panagopoulos, Janaki Makadia, Usama M. Oguz, Akshat Banga, Muhammad Fayaz, William Glass, Claudio Chiastra, Francesco Burzotta, John F. LaDisa, Paul Iaizzo, Yoshinobu Murasato, Gabriele Dubini, Francesco Migliavacca, Timothy MickleyAndrew Bicek, Jason Fontana, Nick E.J. West, Peter Mortier, Pamela J. Boyers, Jeffrey P. Gold, Daniel R. Anderson, James E. Tcheng, John R. Windle, Habib Samady, Farouc A. Jaffer, Nihar R. Desai, Alexandra Lansky, Carlos Mena-Hurtado, Dawn Abbott, Emmanouil S. Brilakis, Jens Flensted Lassen, Yves Louvard, Goran Stankovic, Patrick W. Serruys, Eric Velazquez, Pierre Elias, Deepak L. Bhatt, George Dangas, Yiannis S. Chatzizisis

Surgery

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses on the following applications of AISER: 1) preprocedural planning and clinical decision making; 2) virtual clinical trials, and cardiovascular device research, development, and regulatory approval; and 3) education and training of interventional health care professionals and medical technology innovators. We also discuss the obstacles and constraints associated with the application of AISER technologies, as well as the proposed solutions. Interventional health care professionals, computer scientists, biomedical engineers, experts in bioinformatics and visualization, the device industry, ethics committees, and regulatory agencies are expected to streamline the use of AISER technologies in cardiovascular interventions and medicine in general.

Original language	English (US)
Pages (from-to)	2479-2497
Number of pages	19
Journal	JACC: Cardiovascular Interventions
Volume	16
Issue number	20
DOIs	https://doi.org/10.1016/j.jcin.2023.07.022
State	Published - Oct 23 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors

Keywords

artificial intelligence
cardiovascular intervention
extended reality
precision medicine
procedural planning
simulations
virtual clinical trials

PubMed: MeSH publication types

Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Publisher link

10.1016/j.jcin.2023.07.022

Find It

Find It at U of M Libraries

Cite this

Samant, S., Bakhos, J. J., Wu, W., Zhao, S., Kassab, G. S., Khan, B., Panagopoulos, A., Makadia, J., Oguz, U. M., Banga, A., Fayaz, M., Glass, W., Chiastra, C., Burzotta, F., LaDisa, J. F., Iaizzo, P., Murasato, Y., Dubini, G., Migliavacca, F., ... Chatzizisis, Y. S. (2023). Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions. JACC: Cardiovascular Interventions, 16(20), 2479-2497. https://doi.org/10.1016/j.jcin.2023.07.022

Samant, S, Bakhos, JJ, Wu, W, Zhao, S, Kassab, GS, Khan, B, Panagopoulos, A, Makadia, J, Oguz, UM, Banga, A, Fayaz, M, Glass, W, Chiastra, C, Burzotta, F, LaDisa, JF, Iaizzo, P, Murasato, Y, Dubini, G, Migliavacca, F, Mickley, T, Bicek, A, Fontana, J, West, NEJ, Mortier, P, Boyers, PJ, Gold, JP, Anderson, DR, Tcheng, JE, Windle, JR, Samady, H, Jaffer, FA, Desai, NR, Lansky, A, Mena-Hurtado, C, Abbott, D, Brilakis, ES, Lassen, JF, Louvard, Y, Stankovic, G, Serruys, PW, Velazquez, E, Elias, P, Bhatt, DL, Dangas, G & Chatzizisis, YS 2023, 'Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions', JACC: Cardiovascular Interventions, vol. 16, no. 20, pp. 2479-2497. https://doi.org/10.1016/j.jcin.2023.07.022

@article{ad01e5dd3d21426588b441fdc0a57822,

title = "Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions",

abstract = "Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses on the following applications of AISER: 1) preprocedural planning and clinical decision making; 2) virtual clinical trials, and cardiovascular device research, development, and regulatory approval; and 3) education and training of interventional health care professionals and medical technology innovators. We also discuss the obstacles and constraints associated with the application of AISER technologies, as well as the proposed solutions. Interventional health care professionals, computer scientists, biomedical engineers, experts in bioinformatics and visualization, the device industry, ethics committees, and regulatory agencies are expected to streamline the use of AISER technologies in cardiovascular interventions and medicine in general.",

keywords = "artificial intelligence, cardiovascular intervention, extended reality, precision medicine, procedural planning, simulations, virtual clinical trials",

author = "Saurabhi Samant and Bakhos, {Jules Joel} and Wei Wu and Shijia Zhao and Kassab, {Ghassan S.} and Behram Khan and Anastasios Panagopoulos and Janaki Makadia and Oguz, {Usama M.} and Akshat Banga and Muhammad Fayaz and William Glass and Claudio Chiastra and Francesco Burzotta and LaDisa, {John F.} and Paul Iaizzo and Yoshinobu Murasato and Gabriele Dubini and Francesco Migliavacca and Timothy Mickley and Andrew Bicek and Jason Fontana and West, {Nick E.J.} and Peter Mortier and Boyers, {Pamela J.} and Gold, {Jeffrey P.} and Anderson, {Daniel R.} and Tcheng, {James E.} and Windle, {John R.} and Habib Samady and Jaffer, {Farouc A.} and Desai, {Nihar R.} and Alexandra Lansky and Carlos Mena-Hurtado and Dawn Abbott and Brilakis, {Emmanouil S.} and Lassen, {Jens Flensted} and Yves Louvard and Goran Stankovic and Serruys, {Patrick W.} and Eric Velazquez and Pierre Elias and Bhatt, {Deepak L.} and George Dangas and Chatzizisis, {Yiannis S.}",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = oct,

day = "23",

doi = "10.1016/j.jcin.2023.07.022",

language = "English (US)",

volume = "16",

pages = "2479--2497",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "20",

}

TY - JOUR

T1 - Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

AU - Samant, Saurabhi

AU - Bakhos, Jules Joel

AU - Wu, Wei

AU - Zhao, Shijia

AU - Kassab, Ghassan S.

AU - Khan, Behram

AU - Panagopoulos, Anastasios

AU - Makadia, Janaki

AU - Oguz, Usama M.

AU - Banga, Akshat

AU - Fayaz, Muhammad

AU - Glass, William

AU - Chiastra, Claudio

AU - Burzotta, Francesco

AU - LaDisa, John F.

AU - Iaizzo, Paul

AU - Murasato, Yoshinobu

AU - Dubini, Gabriele

AU - Migliavacca, Francesco

AU - Mickley, Timothy

AU - Bicek, Andrew

AU - Fontana, Jason

AU - West, Nick E.J.

AU - Mortier, Peter

AU - Boyers, Pamela J.

AU - Gold, Jeffrey P.

AU - Anderson, Daniel R.

AU - Tcheng, James E.

AU - Windle, John R.

AU - Samady, Habib

AU - Jaffer, Farouc A.

AU - Desai, Nihar R.

AU - Lansky, Alexandra

AU - Mena-Hurtado, Carlos

AU - Abbott, Dawn

AU - Brilakis, Emmanouil S.

AU - Lassen, Jens Flensted

AU - Louvard, Yves

AU - Stankovic, Goran

AU - Serruys, Patrick W.

AU - Velazquez, Eric

AU - Elias, Pierre

AU - Bhatt, Deepak L.

AU - Dangas, George

AU - Chatzizisis, Yiannis S.

PY - 2023/10/23

Y1 - 2023/10/23

N2 - Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses on the following applications of AISER: 1) preprocedural planning and clinical decision making; 2) virtual clinical trials, and cardiovascular device research, development, and regulatory approval; and 3) education and training of interventional health care professionals and medical technology innovators. We also discuss the obstacles and constraints associated with the application of AISER technologies, as well as the proposed solutions. Interventional health care professionals, computer scientists, biomedical engineers, experts in bioinformatics and visualization, the device industry, ethics committees, and regulatory agencies are expected to streamline the use of AISER technologies in cardiovascular interventions and medicine in general.

AB - Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses on the following applications of AISER: 1) preprocedural planning and clinical decision making; 2) virtual clinical trials, and cardiovascular device research, development, and regulatory approval; and 3) education and training of interventional health care professionals and medical technology innovators. We also discuss the obstacles and constraints associated with the application of AISER technologies, as well as the proposed solutions. Interventional health care professionals, computer scientists, biomedical engineers, experts in bioinformatics and visualization, the device industry, ethics committees, and regulatory agencies are expected to streamline the use of AISER technologies in cardiovascular interventions and medicine in general.

KW - artificial intelligence

KW - cardiovascular intervention

KW - extended reality

KW - precision medicine

KW - procedural planning

KW - simulations

KW - virtual clinical trials

UR - http://www.scopus.com/inward/record.url?scp=85173664297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85173664297&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2023.07.022

DO - 10.1016/j.jcin.2023.07.022

M3 - Review article

C2 - 37879802

AN - SCOPUS:85173664297

SN - 1936-8798

VL - 16

SP - 2479

EP - 2497

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 20

ER -

Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this